Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
March 3, 2026
Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis
MN
Masoud Nikanfar
HY
Hadi Yousefi
AN
Alireza Nourazarian
Key Points
Serum miRNA-155 and TREM2 correlate with neuroinflammation in multiple sclerosis.
Significant changes in biomarkers were observed, indicating disease activity.
Assessment using serum samples from multiple sclerosis patients highlights non-invasive markers.
Findings support the use of miRNA-155 and TREM2 for therapeutic monitoring in clinical settings.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Nikanfar et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d68c6e9836116a276eb
https://doi.org/https://doi.org/10.1007/s12035-026-05697-z
Serum miRNA-155 and TREM2 as Non-Invasive Biomarkers for Monitoring Neuroinflammation and Disease Activity in Multiple Sclerosis | Synapse